• Home

  • Health & Medicine

  • Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel...
76

Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics

Embed Size (px)

Citation preview

Page 1: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 2: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 3: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 4: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 5: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 6: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 7: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 8: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 9: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 10: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 11: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 12: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 13: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 14: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 15: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 16: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 17: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 18: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 19: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 20: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 21: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 22: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 23: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 24: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 25: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 26: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 27: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 28: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 29: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 30: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 31: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 32: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 33: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 34: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 35: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 36: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 37: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 38: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 39: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 40: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 41: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 42: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 43: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 44: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 45: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 46: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 47: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 48: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 49: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 50: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 51: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 52: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 53: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 54: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 55: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 56: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 57: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 58: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 59: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 60: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 61: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 62: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 63: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 64: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 65: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 66: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 67: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 68: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 69: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 70: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 71: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 72: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 73: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 74: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 75: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Page 76: Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics

Hodgkin Lymphoma Klapper

Hodgkin Lymphoma Klapper

Documents
Management of Advanced Stage Hodgkin Lymphoma

Management of Advanced Stage Hodgkin Lymphoma

Documents
NON-HODGKIN LYMPHOMA OF THE BLADDER - SciELO · 499 NON-HODGKIN LYMPHOMA OF THE BLADDER NON-HODGKIN LYMPHOMA OF THE BLADDER ALBERTO A. ANTUNES, LUCIANO J. NESRALLAH, MIGUEL SROUGI

NON-HODGKIN LYMPHOMA OF THE BLADDER - SciELO · 499 NON-HODGKIN LYMPHOMA OF THE BLADDER NON-HODGKIN LYMPHOMA OF THE BLADDER ALBERTO A. ANTUNES, LUCIANO J. NESRALLAH, MIGUEL SROUGI

Documents
Easo workshop Hodgkin Lymphoma case presentation

Easo workshop Hodgkin Lymphoma case presentation

Health & Medicine
Paraneoplastic Syndromes in Children with Hodgkin Lymphoma · Paraneoplastic syndrome, Hodgkin lymphoma, paraneoplastic neurological syndrome, pediatrics, malignancy, vanishing bile

Paraneoplastic Syndromes in Children with Hodgkin Lymphoma · Paraneoplastic syndrome, Hodgkin lymphoma, paraneoplastic neurological syndrome, pediatrics, malignancy, vanishing bile

Documents
Non Hodgkin Lymphoma Presentation

Non Hodgkin Lymphoma Presentation

Documents
Nivolumab in Hodgkin Lymphoma - ER Congressiercongressi.it/slides-lymphoma-conference-2017/23-03/15.Ansell.pdf · Nivolumab in Hodgkin Lymphoma Stephen M. Ansell, MD, PhD Professor

Nivolumab in Hodgkin Lymphoma - ER Congressiercongressi.it/slides-lymphoma-conference-2017/23-03/15.Ansell.pdf · Nivolumab in Hodgkin Lymphoma Stephen M. Ansell, MD, PhD Professor

Documents
Jurnal Hodgkin Lymphoma

Jurnal Hodgkin Lymphoma

Documents
Non-Hodgkin Lymphoma

Non-Hodgkin Lymphoma

Documents
Hodgkin Lymphoma - Brief Information · Hodgkin lymphoma develops from transformed B-lymphocytes, a type of white blood cells (leukocytes) found in lymphatic tissue. Hodgkin lymphoma

Hodgkin Lymphoma - Brief Information · Hodgkin lymphoma develops from transformed B-lymphocytes, a type of white blood cells (leukocytes) found in lymphatic tissue. Hodgkin lymphoma

Documents
Hodgkin Lymphoma Cells

Hodgkin Lymphoma Cells

Documents
Hodgkin lymphoma - dm5migu4zj3pb.cloudfront.net

Hodgkin lymphoma - dm5migu4zj3pb.cloudfront.net

Documents
Hodgkin Lymphoma - CME Syllabuscmesyllabus.com/.../03/hodgkin-lymphoma...Chen_-HL.pdf · • This patient was diagnosed with stage II Hodgkin lymphoma. Background •9000 new cases

Hodgkin Lymphoma - CME Syllabuscmesyllabus.com/.../03/hodgkin-lymphoma...Chen_-HL.pdf · • This patient was diagnosed with stage II Hodgkin lymphoma. Background •9000 new cases

Documents
y NCCN Guidelines for Patients Version 1.2015 Hodgkin Lymphoma · Hodgkin Lymphoma, Version 1.2015 Contents Hodgkin Lymphoma 4 Part 6How to use this book 5 Part 1 Hodgkin lymphoma

y NCCN Guidelines for Patients Version 1.2015 Hodgkin Lymphoma · Hodgkin Lymphoma, Version 1.2015 Contents Hodgkin Lymphoma 4 Part 6How to use this book 5 Part 1 Hodgkin lymphoma

Documents
T-Cell Lymphoma and Hodgkin Lymphoma · T-Cell Lymphoma and Hodgkin Lymphoma Steven M. Horwitz M.D. Associate Member Lymphoma Service Memorial Sloan Kettering Cancer Center • Consultancy:

T-Cell Lymphoma and Hodgkin Lymphoma · T-Cell Lymphoma and Hodgkin Lymphoma Steven M. Horwitz M.D. Associate Member Lymphoma Service Memorial Sloan Kettering Cancer Center • Consultancy:

Documents
Hodgkin lymphoma db.pptx

Hodgkin lymphoma db.pptx

Health & Medicine
Lymphoma Focusing on Hodgkin Disease. Basics Lymphoma – a cancer started in the cells of the immune system 5 types: Hodgkin Disease Non-Hodgkin

Lymphoma Focusing on Hodgkin Disease. Basics Lymphoma – a cancer started in the cells of the immune system 5 types: Hodgkin Disease Non-Hodgkin

Documents
What is non-Hodgkin lymphoma, how is it treated, and what ... › sites...Non-Hodgkin lymphoma •Approximately 1.5 million people worldwide are living with non-Hodgkin lymphoma (NHL)

What is non-Hodgkin lymphoma, how is it treated, and what ... › sites...Non-Hodgkin lymphoma •Approximately 1.5 million people worldwide are living with non-Hodgkin lymphoma (NHL)

Documents
Non-Hodgkin Lymphoma ARTICLE Rituximab maintenance for ...€¦ · transplantation and in women receiving rituximab mainte - nance after second-line autologous stem cell transplanta

Non-Hodgkin Lymphoma ARTICLE Rituximab maintenance for ...€¦ · transplantation and in women receiving rituximab mainte - nance after second-line autologous stem cell transplanta

Documents
Global incidence of non-Hodgkin lymphoma - … · Global incidence of non-Hodgkin lymphoma Non-Hodgkin lymphoma: ... Garcia M, et al. Global Cancer ... and are based on people …

Global incidence of non-Hodgkin lymphoma - … · Global incidence of non-Hodgkin lymphoma Non-Hodgkin lymphoma: ... Garcia M, et al. Global Cancer ... and are based on people …

Documents
Louisiana Cancer Facts & Figures, Non-Hodgkin Lymphoma · Non-Hodgkin Lymphoma •Non-Hodgkin lymphoma was the 6th most common cancer and the 8thleading cause of cancer deaths in

Louisiana Cancer Facts & Figures, Non-Hodgkin Lymphoma · Non-Hodgkin Lymphoma •Non-Hodgkin lymphoma was the 6th most common cancer and the 8thleading cause of cancer deaths in

Documents
Hodgkin lymphoma - PG CME Haematologypgcmehematology.net/articles/016-13-Hodgkin-lymphoma.pdf · Hodgkin lymphoma (HL) ... and Hodgkin cells. In the nodular sclerosis variant, R–S

Hodgkin lymphoma - PG CME Haematologypgcmehematology.net/articles/016-13-Hodgkin-lymphoma.pdf · Hodgkin lymphoma (HL) ... and Hodgkin cells. In the nodular sclerosis variant, R–S

Documents
Classical Hodgkin Lymphoma - relapse

Classical Hodgkin Lymphoma - relapse

Documents
Treatment of Early Stage Hodgkin Lymphoma

Treatment of Early Stage Hodgkin Lymphoma

Documents
LYMPHOMA - Non-Hodgkin lymphoma - Hodgkin lymphoma (Hodgkin disease) Agnieszka Tomaszewska Department of Hematology, Oncology and Internal Medicine, Medical

LYMPHOMA - Non-Hodgkin lymphoma - Hodgkin lymphoma (Hodgkin disease) Agnieszka Tomaszewska Department of Hematology, Oncology and Internal Medicine, Medical

Documents
NON- HODGKIN LYMPHOMA · Non - Hodgkin Lymphoma What you need to know about non-Hodgkin lymphoma 04 05 The exact cause of NHL is unknown. However, NHL is associated with some risk

NON- HODGKIN LYMPHOMA · Non - Hodgkin Lymphoma What you need to know about non-Hodgkin lymphoma 04 05 The exact cause of NHL is unknown. However, NHL is associated with some risk

Documents
Hodgkin lymphoma (HL) - Leukaemia Foundation

Hodgkin lymphoma (HL) - Leukaemia Foundation

Documents
Hodgkin Lymphoma E

Hodgkin Lymphoma E

Documents
Non-Hodgkin Lymphoma (NHL) - Leukaemia Foundation

Non-Hodgkin Lymphoma (NHL) - Leukaemia Foundation

Documents
Radiotherapy in Pediatric Hodgkin Lymphoma

Radiotherapy in Pediatric Hodgkin Lymphoma

Documents